Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.

Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.

Onchocerca volvulus is the nematode pathogen responsible for human onchocerciasis also known as "River blindness", a neglected tropical disease that affects up to 18 million people worldwide. Helminths Excretory Secretory Products (ESPs) constitute a rich repertoire of molecules that can b...

Full description

Bibliographic Details
Main Authors:	Ferdinand Ngale Njume, Stephen Mbigha Ghogomu, Robert Adamu Shey, Lea Olive Tchouate Gainkam, Philippe Poelvoorde, Perrine Humblet, Joseph Kamgno, Annie Robert, Leon Mutesa, Christophe Lelubre, Evelina Edelweiss, Arnaud Poterszman, Susi Anheuser, Luc Vanhamme, Jacob Souopgui
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-07-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0007591

Similar Items

Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.
by: Robert Adamu Shey, et al.
Published: (2018-01-01)

The Functional Parasitic Worm Secretome: Mapping the Place of <i>Onchocerca volvulus</i> Excretory Secretory Products
by: Luc Vanhamme, et al.
Published: (2020-11-01)

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
by: Cabirou Mounchili Shintouo, et al.
Published: (2021-11-01)

In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis
by: Cabirou Mounchili Shintouo, et al.
Published: (2020-06-01)

Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring
by: Bernis Neneyoh Yengo, et al.
Published: (2022-06-01)

Entomological Assessment of <i>Onchocerca</i> Species Transmission by Black Flies in Selected Communities in the West Region of Cameroon
by: Cabirou Mounchili Shintouo, et al.
Published: (2020-09-01)

Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role?
by: Cabirou Mounchili Shintouo, et al.
Published: (2021-08-01)

Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
by: Parakkal Jovvian George, et al.
Published: (2019-09-01)

A lipid transfer protein ensures nematode cuticular impermeability
by: Ferdinand Ngale Njume, et al.
Published: (2022-11-01)

Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
by: Johnny Vlaminck, et al.
Published: (2019-01-01)

The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
by: Fidelis Cho-Ngwa, et al.
Published: (2010-08-01)

Do Communities Really “Direct” in Community-Directed Interventions? A Qualitative Assessment of Beneficiaries’ Perceptions at 20 Years of Community Directed Treatment with Ivermectin in Cameroon
by: Fanny Nadia Dissak-Delon, et al.
Published: (2019-07-01)

Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders’ views
by: Fanny Nadia Dissak-Delon, et al.
Published: (2019-05-01)

Onchocerca - infected cattle produce strong antibody responses to excretory-secretory proteins released from adult male Onchocerca ochengi worms
by: Djafsia Boursou, et al.
Published: (2018-05-01)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017-08-01)

Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate Against Onchocerciasis and Related Filarial Diseases
by: Robert Adamu Shey, et al.
Published: (2021-01-01)

Important progress towards elimination of onchocerciasis in the West Region of Cameroon
by: Guy-Roger Kamga, et al.
Published: (2017-08-01)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
by: Guy-Roger Kamga, et al.
Published: (2018-06-01)

The mitogenome of Onchocerca volvulus from the Brazilian Amazonia focus
by: James L Crainey, et al.
Published: (2016-01-01)

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.
by: Beesan Tan, et al.
Published: (2022-03-01)

Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
by: Mike Y Osei-Atweneboana, et al.
Published: (2011-03-01)

Co-Administration of Adjuvanted Recombinant <i>Ov</i>-103 and <i>Ov</i>-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine <i>Onchocerca ochengi</i> Infection Model of Human Onchocerciasis
by: Lisa Luu, et al.
Published: (2022-05-01)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
by: An Hotterbeekx, et al.
Published: (2020-02-01)

Establishment of an in vitro culture system to study the developmental biology of Onchocerca volvulus with implications for anti-Onchocerca drug discovery and screening.
by: Narcisse V T Gandjui, et al.
Published: (2021-02-01)

√ov Is in the Air
by: Marko Simonović, et al.
Published: (2020-12-01)

Comparison of Diagnostic Tests for <i>Onchocerca volvulus</i> in the Democratic Republic of Congo
by: An Hotterbeekx, et al.
Published: (2020-06-01)

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
by: Sébastien D S Pion, et al.
Published: (2013-01-01)

Individual exposure to <it>Simulium bites and intensity of Onchocerca volvulus infection</it>
by: Enyong P, et al.
Published: (2010-06-01)

Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
by: Sara Lustigman, et al.
Published: (2007-08-01)

Interruption of transmission of Onchocerca volvulus in the Southern Chiapas Focus, México.
by: Mario A Rodríguez-Pérez, et al.
Published: (2013-01-01)

Bacteriome Diversity of Blackflies’ Gut and Association with <i>Onchocerca volvulus</i>, the Causative Agent of Onchocerciasis in Mbam Valley (Center Region, Cameroon)
by: Arnauld Efon Ekangouo, et al.
Published: (2021-12-01)

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
by: Hugues C Nana-Djeunga, et al.
Published: (2014-04-01)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.
by: Robert Colebunders, et al.
Published: (2021-01-01)

Urine metabolites for the identification of Onchocerca volvulus infections in patients from Cameroon
by: Vera Wewer, et al.
Published: (2021-08-01)

Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
by: Rodrigo J Gonzalez, et al.
Published: (2009-01-01)

A four-antigen mixture for rapid assessment of Onchocerca volvulus infection.
by: Peter D Burbelo, et al.
Published: (2009-01-01)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>
by: Alfred Dusabimana, et al.
Published: (2020-12-01)

Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment
by: Guy-Roger Kamga, et al.
Published: (2016-11-01)

Comparison of structural changes in nodding syndrome and other epilepsies associated with Onchocerca volvulus
by: Mazumder, R, et al.
Published: (2022)

Significant heterogeneity in Wolbachia copy number within and between populations of Onchocerca volvulus
by: Samuel Armoo, et al.
Published: (2017-04-01)